United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded May 4, 2026 · Filed May 5, 2026

On May 4, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$576.97 for US$5.48M under a trading plan, leaving 40,513 shares. Filed May 5, 2026 (Form 4).

Sold
9,500 shares
Price
US$576.97 average (US$568.36 to US$582.30)
Value
US$5.48M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Common StockOption exercise9,500US$146.0350,013Direct
May 4, 2026Common StockSale40US$568.3649,973Direct
May 4, 2026Common StockSale120US$569.6449,853Direct
May 4, 2026Common StockSale40US$570.9949,813Direct
May 4, 2026Common StockSale440US$572.4249,373Direct
May 4, 2026Common StockSale359US$574.3749,014Direct
May 4, 2026Common StockSale1,320US$575.4547,694Direct
May 4, 2026Common StockSale3,677US$576.3944,017Direct
May 4, 2026Common StockSale1,039US$577.2642,978Direct
May 4, 2026Common StockSale160US$578.5842,818Direct
May 4, 2026Common StockSale1,104US$579.2741,714Direct
May 4, 2026Common StockSale560US$580.9841,154Direct
May 4, 2026Common StockSale401US$581.7840,753Direct
May 4, 2026Common StockSale240US$582.3040,513Direct

Source

View original at SEC

Related